USPatent applicationPatented

Sanitizing hand cleanser comprising an organic alcohol and silicone based materials

Granted 29 Oct 2002 · no office action yet

Assignee: Vinod K. Narula

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Vinod K. Narula, Dipak Narula · Examiner: Charles Boyer · AU 1751 · TC 1700

Life of the application

6 dated events
⤢ drag to zoom200020022004200620082010201220142016201820202022ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

The present development relates to a liquid cleansing product that effectively reduces the level of microbes on the skin in a relatively short wash time and which dries quickly without causing damage and drying to the skin. The sanitizing cleanser composition comprising an effective amount of organic alcohol to produce a reduction in microorganisms on the surface of the skin, and an additive to maintain the skin pH in the range of from about 4.0 to about 6.0. The cleanser composition may further include silicone to aid further the drying process, and emollients or oils for skin moisturizing.

Description

9 parts
›CROSS-REFERENCE TO PRIOR APPLICATIONS

This application claims priority to U.S. patent application Ser. No. 60/241,900, filed on Oct. 20, 2000, which is incorporated herein by reference.

›BACKGROUND

This invention relates to leave-on, topical antimicrobial compositions that do not require water for antimicrobial effectiveness when applied to the skin. Specifically, the antimicrobial compositions of the present invention use an organic alcohol based solution to provide an essentially immediate reduction of microorganisms on the skin, a silicone additive to aid in the drying process, and an emollient to leave the skin feeling moisturized.

It is well known that cleansing one's hands with soap and hot water is an effective means of reducing microorganisms on the skin surface. However, if the hands are not thoroughly dried, the trace water residue can harbor bacteria. While this may not pose a serious threat to the population at large, in a hospital setting where the population is more prone to infection, it is desirable to minimize any contamination risks.

In the past few years, research efforts have been directed toward formulating a liquid cleansing product that will effectively sanitize the skin without the use of water. Many of these liquid cleansing products incorporate relatively high concentrations or weight percentages of organic alcohols in the compositions. The alcohols allow the product to dry quickly, but also cause the skin to dehydrate to an unacceptable degree, irritating the skin and causing it to crack and chafe.

›SUMMARY OF THE DEVELOPMENT

The present development relates to a liquid cleansing product that is not water-based. When used topically, the cleansing product effectively reduces the level of microbes on the skin in a relatively short wash time. Further, the cleansing product dries quickly without causing damage and drying to the skin with repeated use. As an added benefit, the cleansing product may provide a moisturizing benefit to the skin.

The present invention provides an antimicrobial sanitizing cleanser composition comprising an effective amount of organic alcohol to produce a reduction in microorganisms on the surface of the skin and an additive to maintain the skin pH in the range of from about 4.0 to about 6.0. Specifically, an effective amount of lactic acid, fumed silica, sodium lactate or a combination thereof can be added to balance the skin pH. The cleanser composition may further include silicone to aid further the drying process, and emollients or oils for skin moisturizing. The present invention also relates to methods for reducing the level of microorganisms on the skin using the leave-on antimicrobial compositions described herein.

›DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT

The present development is a composition for a sanitizing hand cleansing product. The product is organic alcohol based with additives to allow the skin to maintain a pH at from about 4.0 to about 6.0, thus reducing the bacteria count on the skin while maintaining the normal flora of the skin. The composition also includes a silicone component which aids in the drying process, and emollients which leave the skin feeling moisturized and refreshed. The antimicrobial compositions of the present invention are highly efficacious for reducing the number of microorganisms on the skin while also being moisturizing and protecting to the skin.

The sanitizing hand cleanser includes one or more organic alcohols to provide antimicrobial functionality, to assist in the drying process, and to serve as a solvent. Preferably, the alcohols are approved for use on human skin, such as ethanol, isopropanol, or a combination thereof. The organic alcohols are present in the formulation at a concentration of from about 60 wt. % to about 90 wt. %.

The hand cleanser also includes one or more additives to allow the skin to maintain a pH of from about 4.0 to about 6.0, such as fumed silica, lactic acid, sodium lactate or a combination thereof. In this pH range, the bacteria count on the skin is reduced while the normal flora of the skin is maintained, potentially providing additional antimicrobial benefits for the cleansing product. An effective amount of additive is included in the formulation to maintain the desired skin pH range, and the amount of additive may range from about 0 wt. % to about 12 wt. %, depending on the additive or combination of additives included in the formulation.

One or more silicone based materials are included in the hand cleanser formulation to further aid the drying process. The silicone based materials, such as cyclomethicone, trimethylsiloxy silicate or a combination thereof, are included in the formulation at a concentration of from about 5 wt. % to about 35 wt. %.

As is known in the art, humectants are added to assist in the retention of liquids within the product, and thickening agents are added to modify the product viscosity. In the present development, any humectant or thickener which does not significantly alter the ability of the formulation to maintain the skin at the desired pH can be used, with the humectant included at a concentration of from about 0 wt. % to about 5 wt. % and the thickener included at a concentration of from about 0 wt. % to about 6.5 wt. %. The thickener may be a cellulose-based material, fumed silica, or a combination thereof, such as methyl cellulose added at concentrations of about 0 wt. % to about 1.5 wt. % used in combination with fumed silica added at concentrations of about 0 wt. % to about 5.0 wt. %.

Optionally, emollients and aesthetic additives, such as fragrance and/or colorants may also be added to the sanitizing hand cleanser formulation. Emollients or moisturizing agents, fragrance and colorants are added as necessary and at concentrations for consumer acceptance. For example, the formulation may include from about 0 wt. % to about 1.5 wt. % fragrance, dye or a combination thereof. The formulation may also include from about 0 wt. % to about 5 wt. % of additional emollients, such as, tea tree oil, hemp oil, aloe-based oil, lanolin, jojoba, chamomile, floral oils, herbal materials or a combination thereof are added to the cleansing product to further aid skin moisturization.

The product is prepared by combining the alcohols, the silicone-based materials, the humectants, and the lactic acid or sodium lactate at ambient temperature in a batch mixing vessel and mixing until well blended. Then a portion of the alcohol mixture is removed to a separate mixing vessel and the thickening agents are added, with mixing, until the mixture thickens slightly. Optionally, the fumed silica is then added to the thickening agent mixture to cause the mixture to thicken further. The thickening agent mixture is then combined with the remaining alcohol mixture while maintaining continuous mixing. The resulting product should have a viscosity that allows the product to be dispensed through a hand-pump, such as is commonly used on liquid soap dispensing bottles. For example, the viscosity could range from about 100 centipoise (cp) to about 100,000 cp at about 25° C. The fragrance may be added at any time that allows for good mixing, such as with the organic alcohol.

The following examples are representative of the hand cleansers which can be prepared in accordance with the present invention. The antimicrobial performance data of some of the cleansers are also included. The cleanser formulations presented are intended for example purposes only and are not intended to be limiting in scope.

›Examples5
›EXAMPLE 1

A sanitizing hand cleanser is prepared which includes about 70 wt. % anhydrous ethanol (3% isopropyl alcohol), about 18.6 wt. % Dow Corning® 345 Fluid (cyclomethicone), about 4.5 wt. % isopropyl myristate, about 1.5 wt. % lactic acid, about 1.5 wt. % sodium lactate (40% active), about 1.3 wt. % Dow Corning® 749 (cyclomethicone and trimethylsiloxysilicate product), about 0.6 wt. % Dow Methocel® OS (methylated cellulose), and about 2.0 wt. % Cabosil M5 fumed silica, commercially available from Cabot Corporation. The product is prepared by mixing the anhydrous ethanol, the 345 Fluid, the isopropyl myristate, the lactic acid, the sodium lactate, and the Dow Corning 749 at ambient temperature in a batch mix tank fitted with at least one agitator or mixing blade until the alcohol mixture is well mixed. Then about 30% of the alcohol mixture is removed to a separate mixing vessel fitted with mixing blades and the Methocel® is added, with mixing, until the mixture thickens slightly. The fumed silica is then added to the Methocel® mixture to cause the mixture to thicken further. The fumed silica/Methocel® mixture is then combined with the remaining alcohol mixture, with continuous mixing, until the fumed silica mixture is completely dissolved in the alcohol mixture. The resulting product has a pH of about 4.5 and has a viscosity of about 350 cp at about 25° C.

›EXAMPLE 2

A sanitizing hand cleanser is prepared which includes about 77.6 wt. % anhydrous ethanol (3% isopropyl alcohol), about 15.5 wt. % Dow Corning® 345 Fluid (cyclomethicone), about 1.5 wt. % isopropyl myristate, about 3.6 wt. % sodium lactate (40% active), about 1.0 wt. % Dow Corning® 749 (cyclomethicone and trimethylsiloxysilicate product), about 0.5 wt. % Dow Methocel® OS, and about 0.3 wt. % fragrance. The product is prepared by mixing the anhydrous ethanol, the 345 Fluid, the isopropyl myristate, the sodium lactate, the Dow Corning 749 and the fragrance at ambient temperature in a batch mix tank fitted with at least one agitator or mixing blade until the alcohol mixture is well mixed. Then about 30% of the alcohol mixture is removed to a separate mixing vessel fitted with mixing blades and the Methocel® is added, with mixing, until the mixture thickens slightly. The Methocel® mixture is then combined with the remaining alcohol mixture, with continuous mixing, until the Methocel® mixture is completely dissolved in the alcohol mixture. The resulting product has a pH of about 4.3 and has a viscosity of about 340 cp at about 25° C.

›EXAMPLE 3

A sanitizing hand cleanser is prepared which is identical to the product of Example 2 except that about 1.5 wt. % of tea tree oil is substituted for about 1.5 wt. % anhydrous ethanol (3% isopropyl alcohol). The product is prepared as in Example 2 with the tea tree oil added in the alcohol mixture. The resulting product has a pH of about 4.4 and has a viscosity of about 360 cp at about 25° C.

›EXAMPLE 4

A sanitizing hand cleanser is prepared which is identical to the product of Example 2 except that about 1.8 wt. % of hemp oil is substituted for about 1.8 wt. % anhydrous ethanol (3% isopropyl alcohol). The product is prepared as in Example 2 with the hemp oil added in the alcohol mixture. The resulting product has a pH of about 4.3 and has a viscosity of about 350 cp at about 25° C.

›EXAMPLE 5

A sanitizing hand cleanser is prepared which is identical to the product of Example 2 except that about 1.0 wt. % of tea tree oil and about 0.5 wt. % of hemp oil is substituted for about 1.5 wt. % anhydrous ethanol (3% isopropyl alcohol). The product is prepared as in Example 2 with the tea tree oil and hemp oil added in the alcohol mixture. The resulting product has a pH of about 4.3 and has a viscosity of about 365 cp at about 25° C.

Antimicrobial Performance Studies:

Antibacterial efficacy of the hand sanitizing cleansers can be evaluated by a variety of known procedures. For example, a minimum inhibitory concentration study may be used to determine the lowest concentration of the cleanser that inhibits growth of a microorganism or a rapid germicidal study may be used to measure the ability of the cleanser to rapidly reduce a known population of microorganisms. Such studies can be conducted using commonly available bacteria and fungi as are listed in Table I.

The minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial agent that inhibits growth of a microorganism. Serial dilutions of the antimicrobial test material are made in broth or agar and then a standardized concentration of the organism is plated onto the agar containing the diluted test material. A variety of organisms are tested against the article to determine the greatest dilution of the article possible while still maintaining antimicrobial efficacy.

Specifically, the product of Example 2 (“Product 2”) is tested for minimum inhibitory concentration (MIC) following a procedure wherein a 1:2 dilution of a test material, by weight, is prepared in Mueller-Hinton Broth or a Brain Heart Infusion Broth. A 200 μL aliquot of the dilution is added to the first well in a row of a microtiter plate. Dilutions of the product are then made starting from the first well with the wells containing dilutions of 1:2, 1:4, 1:8, 1:10, 1:20, 1:50, 1:80, 1:100, 1:150 and 1:200 of the test material. Bacterial and media control wells are also included.

The bacterial organism of interest is scraped from a culture plate and resuspended in phosphate buffered saline solution to an approximate density of 1.0×10 5 cells. An inoculum of approximately 5×10 4 CFU (colony forming units) of each test organism is added to the test wells in a row of the plate and mixed. The plate is incubated at a temperature of 37±2° C. for about 23 hours. Table H summarizes the microbial growth in the test wells in terms of showing growth (+) or showing no growth (0). The MIC is considered to be the lowest dilution in which bacterial growth is completely inhibited in duplicate trials.

Rapid Germicidal Studies

The rapid germicidal studies are used to measure the ability of an antibacterial agent to rapidly reduce a known population of microorganisms. An aliquot of the antibacterial test material is contacted with a known concentration of test bacteria or fungi for a predetermined period of time. The test material is then neutralized, the concentration of the surviving microorganisms is determined, and the efficacy of the antibacterial agent is calculated based on the percentage of microorganisms that did not survive the expose to the antibacterial agent.

For example, the product of Example 2 (“Product 2”) is evaluated for rapid germicidal activity using a protocol wherein a 5 mL aliquot of undiluted Product 2 is placed in a sterile glass jar at 25±1° C. and a 0.5 mL sample of a selected microorganism broth culture yielding an approximate microorganism dilution of about 108 CFU/mL is mixed into the antibacterial material aliquot. After waiting a prescribed time (“exposure time”), 45 mL of a neutralizer solution is added to the glass jar and stirred for 60 seconds. A 1 mL aliquot is removed from the jar—having a microorganism dilution of about 10 −1 - and 10-fold serial dilutions are made to reach a dilution of about 10 −6 . The dilutions are plated in duplicate using a Pour Plate Technique. The plates are inverted and incubated at 35±2° C. for 48±2 hours. Following incubation, the colony forming units per mL (CFU/mL) for surviving organisms are counted and compared to the starting populations. Control samples are included for each organism and exposure time following essentially the same procedure except that the Product 2 is not added in the initial step of the procedure. Table III lists microorganisms for use in the Rapid Germicidal Study, the number of colony forming units per mL for the controls and the test samples (reported in replicate), and the efficacy of the Product 2 as determined by percent reduction in organism count and the log 10 reduction.

From a reading of the above, one with ordinary skill in the art should be able to devise variations to the inventive features. For example, other additives may be included in the formulation to increase consumer acceptance, such as dyes, colorants, skin-softening agents, skin-protecting agents, such as sunscreening materials, and other silicone or non-silicone compounds or solvents that may modify the drying characteristics of organic alcohols or change the tactile feel and dryness caused by high alcohol containing systems. These and other variations are believed to fall within the spirit and scope of the attached claims.

›Tables in the description — 2
TABLE II
OrganismTest Material Well DilutionsControls
ATCCRep.1:21:41:81:101:201:501:801:1001:1501:200BacterialMedia
6303100+++++++++0
6303200+++++++++0
6538100+++++++++0
6538200+++++++++0
65391000++++++++0
65392000++++++++0
7002100+0+++++++0
70022000++++++++0
90271000++++++++0
902720000+++++++0
10231 a100+++++++++0
10231 a20++++++++++0
11229100+++++++++0
11229200+++++++++0
1129610000+++++++0
1129620000+++++++0
11778 b1000++++++++0
11778 b2000++++++++0
12228100+++++++++0
12228200+++++++++0
15313100+++++++++0
15313200+++++++++0
1941810000+++++++0
1941820000+++++++0
33560 c100+0+++++++0
33560 c200+0+++++++0
33592100+++++++++0
33592200+++++++++0
43895100+0+++++++0
438952000++++++++0
5155910++++++++++0
5155920++++++++++0
a Incubation temperature 25 ± 2° C. rather than 37 ± 2° C.
b Incubation temperature 30 ± 2° C. rather than 37 ± 2° C.
c Incubation time of about 25.50 hours at incubation temperature of 42 ± 2° C. with a 5% CO 2 atmosphere
TABLE III
Organ-Expo-
ismsureCount forCount for Test Sample%Log 10
ATCCTimeControlRep 1Rep 2Reduc-Reduc-
#(sec)(CFU/mL)(CFU/mL)(CFU/mL)tiontion
06275152.0 × 10 73.2 × 10 33.4 × 10 399.983.78
06275301.7 × 10 71.4 × 10 32.3 × 10 499.933.15
06275601.4 × 10 71.8 × 10 45.5 × 10 399.913.07
06303159.7 × 10 66.0 × 10 13.3 × 10 399.983.76
06303301.4 × 10 76.1 × 10 21.1 × 10 2>99.99>4.59
06303609.9 × 10 6<1.0 × 10 1<1.0 × 10 1>99.99>6.00
06538153.4 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.53
06538303.1 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.49
06538603.4 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.53
06538156.0 × 10 75.0 × 10 48.4 × 10 399.953.23
06538303.7 × 10 71.6 × 10 4<1.0 × 10 1>99.98>3.67
06538604.6 × 10 71.2 × 10 25.0 × 10 1>99.995.73
06539151.9 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.28
06539301.6 × 10 76.0 × 10 3<1.0 × 10 1>99.98>3.72
06539602.3 × 10 73.5 × 10 32.7 × 10 299.994.08
07002152.0 × 10 7<1.0 × 10 11.4 × 10 3>99.99>4.46
07002302.6 × 10 71.1 × 10 4<1.0 × 10 1>99.98>3.67
07002602.3 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.36
09027152.0 × 10 72.9 × 10 2<1.0 × 10 1>99.99>5.12
09027301.4 × 10 82.4 × 10 5<1.0 × 10 199.913.07
09027601.3 × 10 8<1.0 × 10 12.8 × 10 4>99.99>3.96
09027151.3 × 10 87.0 × 10 42.3 × 10 499.973.45
09027302.0 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.30
09027602.8 × 10 7<1.0 × 10 11.0 × 10 1>99.99>6.45
10231151.0 × 10 61.5 × 10 41.4 × 10 399.182.09
10231301.0 × 10 68.6 × 10 21.5 × 10 199.963.36
10231609.8 × 10 51.2 × 10 23.4 × 10 399.822.73
10231151.1 × 10 67.5 × 10 11.3 × 10 399.943.20
10231309.8 × 10 51.8 × 10 4<1.0 × 10 1>99.08>2.04
10231608.8 × 10 52.8 × 10 21.2 × 10 299.983.64
11229154.0 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.60
11229302.8 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.45
11229603.6 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.56
11296152.4 × 10 72.0 × 10 31.6 × 10 399.994.12
11296302.0 × 10 71.1 × 10 36.5 × 10 199.994.54
11296602.1 × 10 73.8 × 10 3<1.0 × 10 1>99.99>4.04
11778158.2 × 10 51.8 × 10 3<1.0 × 10 1>99.89>2.96
11778308.2 × 10 5<1.0 × 10 1<1.0 × 10 1>99.99>4.91
11778608.6 × 10 52.6 × 10 31.0 × 10 199.852.82
12228151.4 × 10 79.6 × 10 38.4 × 10 499.662.48
12228301.2 × 10 71.5 × 10 35.0 × 10 499.782.66
12228601.4 × 10 71.5 × 10 17.2 × 10 399.973.59
15313154.3 × 10 73.0 × 10 51.8 × 10 599.442.25
15313304.7 × 10 7<1.0 × 10 16.9 × 10 3>99.99>4.14
15313604.8 × 10 73.4 × 10 41.7 × 10 599.792.68
19418151.7 × 10 73.5 × 10 24.7 × 10 399.993.85
19418301.5 × 10 71.2 × 10 45.0 × 10 499.792.69
19418601.6 × 10 71.0 × 10 39.8 × 10 399.973.47
22019159.0 × 10 51.0 × 10 36.0 × 10 399.612.41
22019309.5 × 10 56.2 × 10 25.4 × 10 299.943.22
22019601.6 × 10 6<1.0 × 10 1<1.0 × 10 1>99.99>5.20
33592151.4 × 10 77.4 × 10 42.6 × 10 598.781.92
33592301.1 × 10 7<1.0 × 10 12.2 × 10 3>99.99>4.00
33592601.4 × 10 71.6 × 10 31.8 × 10 399.993.92
33650155.6 × 10 66.0 × 10 21.8 × 10 399.983.67
33650304.9 × 10 6<1.0 × 10 1<1.0 × 10 1>99.99>5.69
33650606.2 × 10 63.0 × 10 1<1.0 × 10 1>99.99>5.19
43895154.2 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.62
43895304.8 × 10 75.3 × 10 3<1.0 × 10 1>99.99>4.27
43895603.0 × 10 7<1.0 × 10 1<1.0 × 10 1>99.99>6.48
51559154.0 × 10 74.0 × 10 1<1.0 × 10 1>99.99>6.02
51559304.6 × 10 5<1.0 × 10 1<1.0 × 10 1>99.99>6.66
51559608.8 × 10 54.0 × 10 3<1.0 × 10 1>99.99>4.30

Claims as granted

36 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

17 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K8/25
  • A61K8/34
  • A61K8/365
  • A61Q17/00
  • A01N31/02
  • A61K8/58
Section C — Chemistry; metallurgy
  • C11D1/66
  • C11D3/12
  • C11D3/16
  • C11D3/43
  • C11D3/20
  • C11D9/36
USPC · US Patent Classification
510/138510/407510/432510/466510/157

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomOct 2001Jan 2002Apr 2002Jul 2002Oct 2002USPTOApplicantNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.1 y
385 days filing → grant
Office actions
0
none on record
Examiner
Charles Boyer
art unit 1751 · TC 1700
Citations: 13 back · 28 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

No assignments have been recorded for this application yet.